2nd Annual Multi-Functional Cell Therapies Summit
Cell therapies hold life-saving potential for patients and the race is on to develop best-in-class, living, 'thinking' drugs. Relapse rates and barriers to solid tumor efficacy mean the cell therapy industry must innovate, now more than ever.
Due to its successful first edition, the Multi-Functional Cell Therapies Summit is returning for 2022 and will be uniting global leaders to discuss strategies to weaponize cell therapies with antigenic, engineered, and combination approaches to create sophisticated multi-functional systems.
View the full event brochure here: https://ter.li/6o9ghc
The 2nd Annual Multi-Functional Cell Therapies Summit remains the only cell-type agnostic, targeting focused meeting providing a platform for overcoming the challenges to weaponizing cell therapies against solid tumors such as:
-Understanding and overcoming the immunosuppressive nature of the TME to inform future drug development
-Exploiting multiple functions through innovative engineering and novel targeting approaches to produce "smarter" cell therapies with high efficacy and safety profiles
-Synergizing analytical strategy with efficient and standardized manufacturing to overcome regulatory barriers preventing approval
Join us as we bring together drug developers and innovators to tackle unique cell therapy development challenges creating obstacles for effective treatments for solid tumor patients.
Register for your ticket here: https://ter.li/ntcd3z